Werewolf Therapeutics (HOWL) finance VP reports stock and option holdings on Form 3
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Werewolf Therapeutics, Inc. VP of Finance & Corporate Controller Michael J. Urban filed an initial Form 3 showing his equity holdings. He directly holds stock options covering 52,500 shares at an exercise price of $3.6500, 29,365 shares at $4.6400, 10,000 shares at $1.5700, and 54,800 shares at $1.5600, with expiration dates ranging from 2033 to 2035. He also directly owns 5,284 shares of Werewolf Therapeutics common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Urban Michael J.
Role
VP of Finance & Corp. Contr.
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 52,500 shares (Direct);
Common Stock — 5,284 shares (Direct)
Footnotes (1)
- The option was granted on June 1, 2023. The shares underlying the option vested as to 25% on May 15, 2024, and the remainder vest in substantially equal monthly installments thereafter through May 15, 2027. The option was granted on January 2, 2024 with a Vesting Commencement Date of January 1, 2024. The shares underlying the option vest in substantially equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2028. The option was granted on December 19, 2024, and is fully vested. The option was granted on January 2, 2025 with a Vesting Commencement Date of January 1, 2025. The shares underlying the option vest in substantially equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2029.
FAQ
What does the HOWL Form 3 filing by Michael J. Urban show?
The Form 3 shows VP of Finance & Corporate Controller Michael J. Urban’s initial ownership in Werewolf Therapeutics, Inc., including multiple option grants and common stock, as he becomes a reporting insider under SEC rules.
How many Werewolf Therapeutics (HOWL) stock options does Michael J. Urban hold?
Michael J. Urban holds several stock option positions on Werewolf Therapeutics common stock: 52,500 shares at $3.6500, 29,365 at $4.6400, 10,000 at $1.5700, and 54,800 at $1.5600, all held directly with expirations between 2033 and 2035.
What common stock holdings of Werewolf Therapeutics (HOWL) are reported on this Form 3?
The Form 3 reports that Michael J. Urban directly owns 5,284 shares of Werewolf Therapeutics common stock. This is separate from his stock option holdings and represents current issued and outstanding shares held in his name.
Are the stock options in the HOWL Form 3 already vested?
Some options are fully vested while others vest over time. Footnotes state one grant is fully vested, while others vest 25% initially or in substantially equal monthly installments through dates ranging from May 15, 2027 to January 1, 2029.
What are the expiration dates of Michael J. Urban’s HOWL stock options?
The reported stock options on Werewolf Therapeutics common stock expire on dates between May 31, 2033 and January 1, 2035. Each option series has its own specific expiration date tied to the original grant terms.
Does the HOWL Form 3 indicate any recent insider buying or selling?
No buy or sell transactions are indicated. The entries are classified as holdings with unknown transaction codes, reflecting Mr. Urban’s existing positions rather than new market purchases or sales of Werewolf Therapeutics securities.